Melin J, Cano S, Pendrill L. The Role of Entropy in Construct Specification Equations (CSE) to Improve the Validity of Memory Tests. Entropy (Basel). 2021;23(2).
Calvert M, King M, Mercieca-Bebber R, et al. SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials. BMJ Open. Jun 30 2021;11(6):e045105.
Regnault A. A brief (non-exhaustive) overview of recent applications of mixed methods research in patient-centred outcome research. Paper presented at: ISOQOL (Industry SIG symposium)2020.
Marquis S, Regnault A. Psychometric analyses of repeated measures using longitudinal extensions of the Rasch model and partial credit model with invariant frame of reference over time. Paper presented at: ISOQOL (oral presentation)2020.
Loubert A, Regnault A, Sébille V, et al. Contemplating clinical trials as measurement systems: A new perspective for measurement uncertainty associated with treatment benefit demonstration. Paper presented at: ISOQOL (oral presentation)2020.
Loubert A, Regnault A, Sébille V, Cano S, Hardouin JB. Should we calibrate PRO instruments in clinical trials? A comprehensive simulation study based on Rasch Measurement Theory. ISOQOL; 2020.
Regnault A, Martin M, Eremenco S, McLeod L, Hudgens S. Clinical Outcome Assessment in a Multi Cultural Context: Measurement Challenges and Solutions (workshop). ISOQOL; 2019; San Diego, CA, USA.
Pendrill L, Melin J, J Cano S, consortium tENH. Metrological references for health care based on entropy. International Congress of Metrology. 2019:07001.
Loubert A, Regnault A, Sébile V, Cano S, Hardouin JB. Calibrating Rasch measures for assessing treatment effects in a clinical trial setting: Findings from a simulation study. ISOQOL; San Diego, CA, USA, 2019.
Cleanthous S, Barbic SP, Smith S, Regnault A. Psychometric performance of the PROMIS(R) depression item bank: a comparison of the 28- and 51-item versions using Rasch measurement theory. J Patient Rep Outcomes. 2019;3(1):47.
Smith S, Cano S, Browne J. Patient reported outcome measurement: drawbacks of existing methods. BMJ (Clinical research ed). 2019;364:l844.
Melin J, Pendrill LR, Cano SJ. Towards patient-centred cognition metrics. IMEKO TC1-TC7-TC13-TC18 Joint Symposium 2019; 2019; St Petersburg, Russia.
Cano SJ, Pendrill LR, Melin J, Fisher WP. Towards consensus measurement standards for patient-centered outcomes. Measurement. 2019;141:62-9.
Browne JP, Cano SJ. A Rasch Measurement Theory Approach to Improve the Interpretation of Patient-reported Outcomes. Medical care. 2019;57 Suppl 5 Suppl 1:S18-s23.
Regnault A, Cleanthous S, Markowitz JT, Marquis P, Cano SJ. A Mixed Methods Psychometrics Framework to Reduce the Uncertainty in the Measurement of Patient-Centered Outcomes. Institute of Objective Measurement Workshop; 2018; New York, NY, USA.
Pendrill LR, Cano S, Köbe T, Melin J, Fillmer A. Restitution of ability and difficulty from decision-making: metrology of human-based perceptions. Measurement at the Crossroads: History, Philosophy, and Sociology of Measurement; 2018; Paris, France.
Markowitz J, Regnault A, Cleanthous S, Marquis P, Cano S. Picking up the pace: the case for mixed methods research in pharmaceutical clinical trials. Society of Behavioral Medicine; New Orleans, LA, USA, 2018.
Cano SJ, Pendrill LR, Melin J, Köbe T, Fisher WP, Stenner AJ. Metrology for the Social Sciences: A case for Rasch Measurement Theory (not Rasch Analysis). Institute of Objective Measurement Workshop; 2018; New York, NY, USA.
Cano SJ, Pendrill LR, Barbic SP, Fisher WP. Patient-centred outcome metrology for healthcare decision-making. Journal of Physics: Conference Series. 2018;1044(1):012057.
Cano SJ. Generalizability of validity data across diseases and treatment settings: when is enough, enough? ISOQOL; 2018; Dublin, Ireland.
Cano S, Melin J, Fisher WP, Stenner AJ, Pendrill L, EMPIR-NeuroMet-15HLT04-consortium. Patient-centred cognition metrology. Journal of Physics: Conference Series. 2018;1065:072033.
Calvert M, Kyte D, Mercieca-Bebber R, Slade A, Chan AW, King MT, et al. Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension. Jama. 2018;319(5):483-94.
Brundage M, Wu AW, Rivera Y, Cano S, Dueck A, Jensen R, et al. Methods for aiding interpretation of PRO scores. ISOQOL; 2018; Dublin, Ireland.
Regnault A, Willgoss T, Barbic S. Towards the use of mixed methods inquiry as best practice in health outcomes research. Journal of Patient-Reported Outcomes. 2017;2(1):19.
Powers JH, 3rd, Patrick DL, Walton MK, Marquis P, Cano S, Hobart J, et al. Clinician-Reported Outcome Assessments of Treatment Benefit: Report of the ISPOR Clinical Outcome Assessment Emerging Good Practices Task Force. Value Health. 2017;20(1):2-14.
Mcclimans L, Browne J, Cano S. Clinical outcome measurement: Models, theory, psychometrics and practice. Studies in History and Philosophy of Science. 2017;65-66:67-73.
Browne JP, Cano SJ, Smith S. Using Patient-reported Outcome Measures to Improve Health Care: Time for a New Approach. Medical care. 2017;55(10):901-4.
Rixon L, Baron J, McGale N, Lorencatto F, Francis J, Davies A. Methods used to address fidelity of receipt in health intervention research: a citation analysis and systematic review. BMC health services research. 2016;16(1):663.
Cleanthous S, Marquis P, Strzok S, Pompilus F, Regnault A, Cano S. Why we should move mixed methods in psychometric research from a three-step to a" two-step''. ISOQOL; 2016; Copenhagen, Denmark.
Cano SJ, Pendrill L. Why the quality of person-centred metrics counts in healthcare: past, principles and progress. University of Gothenburg Centre for Person-centred Care (GPCC) seminar; 2016; Göteborg, Sweden
Cano SJ. PRO Measurement in 2016: Instrument Development and Modern Psychometrics. Patient Reported Outcomes in Surgery Conference, Plastic Surgery Education Foundation/Council of Medical Specialties; 2016; Washington DC, USA
Cano S, Vosk T, Pendrill L, Stenner J. On trial: the compatibility of measurement in the physical and social sciences. IMEKO TC1-TC7-TC13 Joint Symposium; 2016; Berkeley, CA, USA
Walton MK, Powers JH, 3rd, Hobart J, Patrick D, Marquis P, Vamvakas S, et al. Clinical Outcome Assessments: Conceptual Foundation-Report of the ISPOR Clinical Outcomes Assessment - Emerging Good Practices for Outcomes Research Task Force. Value Health. 2015;18(6):741-52.
Symonds T, Wyrwich KW, Regnault A, Coons SJ. Moving the Science Forward: Tackling Key Psychometric and Methodological Issues Facing the Field of Clinical Outcome Assessment. ISPOR; 2015; Milan, Italy.
Salzberger T, Cano S. Investigating a lack of discrimination between two adjacent response categories in the Rasch model for ordered categories in health measurement. International Outcome Measurement Conference; 2015; Chicago, IL, USA
Regnault A, Herdman M. Using quantitative methods within the Universalist model framework to explore the cross-cultural equivalence of patient-reported outcome instruments. Qual Life Res. 2015;24(1):115-24.
Regnault A, Hamel JF, Patrick DL. Pooling of cross-cultural PRO data in multinational clinical trials: how much can poor measurement affect statistical power? Qual Life Res. 2015;24(2):273-7.
Petrillo J, Cano SJ, McLeod LD, Coon CD. Using classical test theory, item response theory, and Rasch measurement theory to evaluate patient-reported outcome measures: a comparison of worked examples. Value Health. 2015;18(1):25-34.
Cano S, Hobart J. Individual vs group level measurement: Implications for health care outcome economics. International Outcome Measurement Conference; 2015; Chicago, IL, USA
Cano S. Social Measurement: Three Problems, Five Challenges, One Solution. The Making of Measurement, CRASSH 2015; University of Cambridge, UK.
Cano S. New Psychometric Methods - Implications for Surgery. Patient Reported Outcomes in Surgery Conference, American College of Surgeons; 2015; Washington, D.C., USA
Moderator: Regnault A, Speakers: Symonds T, Houyez F, Arnould B. Can Mixed Methods Research be the Solution to the Challenges of Patient-Centered Outcome Research in the Context of Rare Diseases? . ISPOR; 2014; Amsterdam, The Netherlands.
Fofana F, Bonnaud-Antignac A, Regnault A. A mixed method approach to help demonstrate saturation in qualitative research: applying Partial Least Square regression to qualitative data. 1st Mixed Methods International Research Association (MMIRA) Annual Conference; 2014; Boston, USA.
Anthoine E, Moret L, Regnault A, Sebille V, Hardouin JB. Sample size used to validate a scale: a review of publications on newly-developed patient reported outcomes measures. Health Qual Life Outcomes. 2014;12:176.
Acquadro C, Regnault A, Arnould B. Regulatory Issues in Pro Advertising: A Review of the Ddmac/Opdp Letters From 1998 To 2013 To Identify Pro Claims Violations and Examine Their Evolution Over Time. ISPOR; Amsterdam, The Netherlands, 2014.
Petrillo J, Cano SJ, McLeod LD, Coon CD. Which paradigm for evaluating patient-reported outcome instruments? A comparison of classical test theory, item response theory, and rasch measurement theory. ISOQOL; 2013; Miami, FL, USA
Moderator: Regnault A, Speakers: Patrick D, Carrita P, Pavlovic M. Demonstrating treatment benefit using clinical outcomes assessments in global clinical trials: how reliable are the assessments from cross-cultural settings? ISPOR; 2013; Dublin, Ireland.
Fofana F, Bonnaud-Antignac A, Guillemin I, Marrel A, Beriot-Mathiot A, Regnault A. A mixed method approach to saturation: applying partial least square regression to qualitative data. ISOQOL 20th Annual Conference; Miami, FL, USA, 2013.
Fofana F, Bonnaud-Antignac A, Guillemin I, Marrel A, Beriot-Mathiot A, Regnault A. Applying partial least square regression to further explore concept structure and interviewee profiles in qualitative research. ISOQOL 20th Annual Conference; Miami, FL, USA, 2013.
Cleanthous S, Molin A, Senior V, Wearden A. The role of Health Psychologists in Applied Settings: An online survey and interviews with Health Psychology Practitioners. Health Psychology Update. 2013;22(1):30-7.
Cano S. Developments in rating scale methods. Dementias & Neurodegenerative Diseases Research Network Annual Conference; 2013; London, UK
Regnault A, Arnould B, Anfray C. Assessing Health Outcomes in a Global Clinical Research Setting: Challenges and Solutions to Manage Cultural Variability. ISOQOL; 2012; Budapest, Hungary.
Regnault A, Hamel JF, Patrick DL. Pooling of cross-cultural PRO data in multinational clinical trials: How much can poor measurement affect statistical power? ISOQOL; Denver, CO, USA, 2011.
Regnault A, Gilet H, Meunier J, Arnould B. Statistical approach to development and validation of patient-reported outcomes tools for individual decision-making. International symposium on Patient-Reported Outcome and Quality of Life; 2011; Paris, France.
Regnault A, Arnould B, Anfray C. Managing Cultural Variability in PRO Measurement in a Global Clinical Research Setting. ISOQOL; 2011; Denver, USA.
Marquis P, Caron M, Emery M-P, Scott J, Arnould B. The Role of Health-Related Quality of Life Data in the Drug Approval Processes in the US and Europe: A Review of Guidance Documents and Authorizations of Medicinal Products from 2006 to 2010. Pharm Med. 2011;25(3):147-60.
Hobart JC, Cano SJ. Rasch analysis. In: Jenkinson, Peter, Bromberg, editors. Quality of Life Measurement in Neurodegenerative and Related Conditions. Cambridge: Cambridge University Press; 2011.
Cano SJ, Hobart JC. The problem with health measurement. Patient Prefer Adherence. 2011;5:279-90.
Cano SJ, Barrett LE, Zajieck JP, Hobart JC. Dimensionality is a relative concept. Multiple Sclerosis Journal. 2011;17(7):893-4.
Viala-Danten M, Regnault A, Berdeaux G. The interpretation of patient-reported outcome data: a challenge for statisticians? International Society for Clinical Biostatistics; Montpellier, France, 2010.
Lasch KE, Marquis P, Vigneux M, Abetz L, Arnould B, Bayliss M, et al. PRO development: rigorous qualitative research as the crucial foundation. Qual Life Res. 2010;19(8):1087-96.
Hobart JC, Cano SJ, Thompson AJ. Effect sizes can be misleading: is it time to change the way we measure change? Journal of neurology, neurosurgery, and psychiatry. 2010;81(9):1044-8.
Hobart JC, Cano SJ. Effect sizes can be misleading: Is it time to change the way we measure change? . ISOQOL; 2010; London, UK
Gorecki C, Nixon J, Lamping DL, Brown JM, Cano S. The benefits of mixed methods in scale development II: Selecting optimal mode of administration ISOQOL; 2010; London, UK
Gorecki C, Lamping DL, Nixon J, Brown JM, Cano S. The benefits of mixed methods in scale development I: The added value of Rasch analysis in pre-testing. ISOQOL; London, UK, 2010.
Regnault A, Gilet H, Carita P, Arnould B. Exploring patients' satisfaction with anticoagulant treatmentby applying Structural Equation Models to the Perception of AntiCoagulant Treatment Questionnaire (PACT-Q). ISPOR; Paris, France, 2009.
Regnault A, Carita P, Gilet H, Arnould B. Modélisation par équations structurelles de la satisfaction des patients vis-à-vis de leur traitement anticoagulant. Modèles et Apprentissage en Sciences Humaines et Sociales; 2009; Toulouse, France.
Regnault A, Mear I, Marfatia S, Mollon P. Addressing cross-cultural issues with Patient-Reported Outcomes assessments to strengthen evidence obtained in an international context. ISPOR; 2008; Athens, Greece.
Magnussen K, Quere S, Winkel P. Use of statistical process control in the production of blood components. Transfusion medicine (Oxford, England). 2008;18(3):190-6.
Cano SJ, Hobart JC. Watch out, watch out, the FDA are about. Developmental medicine and child neurology. 2008;50(6):408-9.
Cano SJ, Hobart JC. Item response (letter). The Psychologist. 2008;21(2):169.
Regnault A, Arnould B. Partial least squares (PLS) discriminant analysis: a method of choice for developing clinical decision-support tools from patient reported outcomes (PRO) data. ISOQOL; Budapest, Hungary, 2007.
Regnault A, de la Loge C, Bounekkar A, Lamure M. Le fonctionnement différentiel de l'item dans la démarche d'évaluation de la validité transculturelle des questionnaires patients. Sante et Systemique. 2006;9(1-2):175-203.
Regnault A, de la Loge C, Bounekkar A, Lamure M. Detection of Differential Item Functioning with Ordinal Response Format: Application of Ordinal Log-Linear Models. 5th Conference of the International Test Commission; 2006; Brussels, Belgium.
Regnault A, de la Loge C, Arnould B, Lamure M. Quantitative aspects of an Operational Procedure to Assess Cross-Cultural Equivalence: Description and Applications. ISOQOL; 2006; Lisboa, Portugal.
Marquis P, Arnould B, Acquadro C, Roberts WM. Patient-Reported Outcomes and Health-Related Quality of Life in effectiveness studies: pros and cons. Drug Development Research. 2006;67(3):193-201.
Cano SJ, O'Connor RJ, Thompson AJ, Hobart JC. Exploring disability rating scale responsiveness II: do more response options help? Neurology. 2006;67(11):2056-9.
Smith SC, Cano SJ, Browne JP, Lamping DL, Black NA, van der Meulen J, et al. Patient-Reported Outcome Measures (PROMs) for Routine use in Treatment Centres: Recommendations Based on A Review of the Scientific Evidence. London: Health Services Research Unit, London School of Hygiene & Tropical Medicine, London, UK; 2005.
Regnault A, de la Loge C, Conway K, Lamure M. How could quantitative methods contribute to the assessment of a PRO instrument's Cross-cultural Equivalence? ISOQOL; San Fransisco, USA, 2005.
Marquis P, Keininger D, Acquadro C, De La Loge C. Translating and evaluating questionnaires: cultural issues for international research. In: Fayers P, Hays R, editors. Assessing Quality of Life in Clinical Trials. New York: Oxford University Press; 2005. p. 77-93.
Hasle-Pham E, Arnould B, Spath HM, Follet A, Duru G, Marquis P. Role of clinical, patient-reported outcome and medico-economic studies in the public hospital drug formulary decision-making process: results of a European survey. Health Policy. 2005;71(2):205-12.
Marquis P, Chassany O, Abetz L. A comprehensive strategy for the interpretation of quality-of-life data based on existing methods. Value Health. 2004;7(1):93-104.
Barberger-Gateau P, Alioum A, Peres K, Regnault A, Fabrigoule C, Nikulin M, et al. The contribution of dementia to the disablement process and modifying factors. Dement Geriatr Cogn Disord. 2004;18(3-4):330-7.
Arnould B, Regnault A, Girod I, Dubois D. Psychometric Tools designed for Medical Decision Making: Methodological and Analytical issues in item reduction, scoring, decision rule definition, and assessment of predictive validity. European Society for Medical Decision Making 9th Biennial Conference; 2004; Rotterdam, The Netherlands.
Arnould B, de la Loge C, Abetz L, Regnault A, Duru G. Screeners, symptom and disability scales for use in clinical practice: their contribution to improve the use of drugs. ISPOR; 2004; Hamburg, Germany.
Alioum A, Peres K, Verret C, Regnault A, Barberger-Gateau P. Determinants of progression and recovery through states of disability: use of a Markov model with piecewise constant intensities and covariates. Longevity, aging and degradation models; 2004; St Petersburg.
Cano SJ, Warner TT, Hobart JC. What sample sizes for reliability and validity studies II: a prospective study. ISOQOL; 2003; Prague, Czech Republic
Acquadro C, Berzon R, Dubois D, Leidy NK, Marquis P, Revicki D, et al. Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001. Value Health. 2003;6(5):522-31.
Symonds T, Berzon R, Marquis P, Rummans TA. The clinical significance of quality-of-life results: practical considerations for specific audiences. Mayo Clin Proc. 2002;77(6):572-83.
Chassany O, Sagnier PP, Marquis P, Fullerton S, Aaronson N, Group FtERIoQoLA. Patient-reported outcomes: the example of health-related quality of life – A European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Information Journal. 2002;36(1):209-38.
Marquis P. Health-related quality of life (HRQL). Value Health. 2001;4(4):344-5.
Jambon B, Marquis P, Burke LB, Kind P, Kline Leidy N, Barofsky I, et al. A decisive step towards the recognition of patient reported outcomes in clinical trials. Quality of Life Newsletter. 2001;26:24-5.
Acquadro C, Jambon B, Ellis D, Marquis P. Language and Translation Issues. In: Spilker B, editor. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia: Lippincott-Raven Publishers; 1996. p. 575-85.